دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Intellectual and developmental disabilities—an under-recognised driver of cancer mortality
doi : 10.1016/S1470-2045(24)00146-3
Volume 25, Issue 4, April 2024, Page 411
The cost and value of cancer medicines in Ontario, Canada
Christopher J Longo
doi : 10.1016/S1470-2045(24)00099-8
Volume 25, Issue 4, April 2024, Pages 412-413
Venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia
Lin Yang, *Versha Banerji
doi : 10.1016/S1470-2045(24)00136-0
Volume 25, Issue 4, April 2024, Pages 413-414
A new era of risk prediction for patients with high-risk melanoma
*Roger Olofsson Bagge, Tina J Hieken
doi : 10.1016/S1470-2045(24)00101-3
Volume 25, Issue 4, April 2024, Pages 415-416
Combining chemotherapy and immunotherapy for advanced anal cancer: are we ready?
*Erika Martinelli, Davide Ciardiello
doi : 10.1016/S1470-2045(24)00131-1
Volume 25, Issue 4, April 2024, Pages 416-417
Towards world-class radiotherapy in the UK: time for transformation
Katie Wakeham, Tim Cooper, Carl Rowbottom, Anthony J Chalmers, Katie Spencer, Pat Price, Sarah Quinlan
doi : 10.1016/S1470-2045(24)00103-7
Volume 25, Issue 4, April 2024, Pages 418-419
Correction to Lancet Oncol 2023; 24: 1399–410
doi : 10.1016/S1470-2045(24)00078-0
Volume 25, Issue 4, April 2024, Page e137
Correction to Lancet Oncol 2024; 25: 317–25
doi : 10.1016/S1470-2045(24)00144-X
Volume 25, Issue 4, April 2024, Page e137
South Africa combats gaps in cancer data
Manjulika Das
doi : 10.1016/S1470-2045(24)00106-2
Volume 25, Issue 4, April 2024, Page 420
Indonesia and the Philippines take steps to control cancer
Manjulika Das
doi : 10.1016/S1470-2045(24)00132-3
Volume 25, Issue 4, April 2024, Page 421
Non-communicable diseases in humanitarian settings
Talha Burki
doi : 10.1016/S1470-2045(24)00138-4
Volume 25, Issue 4, April 2024, Page 422
Alabama Supreme Court's “extrauterine children� decision alarms oncologists and fertility experts
Bryant Furlow
doi : 10.1016/S1470-2045(24)00139-6
Volume 25, Issue 4, April 2024, Pages 423-424
Massive US cybersecurity breach highlights perils of health-care consolidation
Bryant Furlow
doi : 10.1016/S1470-2045(24)00149-9
Volume 25, Issue 4, April 2024, Page e138
Innovation in gynaecological cancer: highlighting global disparities
doi : 10.1016/S1470-2045(24)00137-2
Volume 25, Issue 4, April 2024, Pages 425-430
Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional study
Joseph C Del Paggio, Rohini Naipaul, Scott Gavura, Rebecca E Mercer, Rachel Koven, Bishal Gyawali, Brooke E Wilson, Christopher M Booth
doi : 10.1016/S1470-2045(24)00072-X
Volume 25, Issue 4, April 2024, Pages 431-438
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
Egbert F Smit, Enriqueta Felip, Dipesh Uprety, Misako Nagasaka, Kazuhiko Nakagawa, Luis Paz-Ares Rodr?guez, Jose M Pacheco, Bob T Li, David Planchard, Christina Baik, Yasushi Goto, Haruyasu Murakami, Andreas Saltos, Kaline Pereira, Ayumi Taguchi, Yingkai Cheng, Qi Yan, Wenqin Feng, Zenta Tsuchihashi, Pasi A J?nne
doi : 10.1016/S1470-2045(24)00064-0
Volume 25, Issue 4, April 2024, Pages 439-454
Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis
Bernardo Haddock Lobo Goulart, Sirisha L Mushti, Somak Chatterjee, Erin Larkins, Pallavi S Mishra-Kalyani, Richard Pazdur, Paul G Kluetz, Harpreet Singh
doi : 10.1016/S1470-2045(24)00040-8
Volume 25, Issue 4, April 2024, Pages 455-462
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
doi : 0.1016/S1470-2045(24)00070-6
Volume 25, Issue 4, April 2024, Pages 463-473
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
Rachel M Layman, Hyo S Han, Hope S Rugo, Erica M Stringer-Reasor, Jennifer M Specht, E Claire Dees, Peter Kabos, Samuel Suzuki, Sarah C Mutka, Brian F Sullivan, Igor Gorbatchevsky, Robert Wesolowski
doi : 10.1016/S1470-2045(24)00034-2
Volume 25, Issue 4, April 2024, Pages 474-487
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study
Benjamin L Musher, Eric K Rowinsky, Brandon G Smaglo, Wasif Abidi, Mohamed Othman, Kalpesh Patel, Salmaan Jawaid, James Jing, Amanda Brisco, Ann M Leen, Mengfen Wu, Linda C Sandin, Jessica Wenthe, Emma Eriksson, Gustav J Ullenhag, Bambi Grilley, Justyna Leja-Jarblad, Susan G Hilsenbeck, Malcolm K Brenner, Angelica S I Loskog
doi : 10.1016/S1470-2045(24)00079-2
Volume 25, Issue 4, April 2024, Pages 488-500
68Ga-RM2 PET–MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial
Heying Duan, Farshad Moradi, Guido A Davidzon, Tie Liang, Hong Song, Andreas M Loening, Shreyas Vasanawala, Sandy Srinivas, James D Brooks, Steven Hancock, Andrei Iagaru
doi : 10.1016/S1470-2045(24)00069-X
Volume 25, Issue 4, April 2024, Pages 501-508
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis
Robert C Stassen*, Carolien C H M Maas*, Astrid A M van der Veldt, Serigne N Lo, Robyn P M Saw, Alexander H R Varey, Richard A Scolyer, Georgina V Long, John F Thompson, Piotr Rutkowski, Ulrich Keilholz, Alexander C J van Akkooi, Cornelis Verhoef, David van Klaveren, Dirk J Grünhagen
doi : 10.1016/S1470-2045(24)00076-7
Volume 25, Issue 4, April 2024, Pages 509-517
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study
Stefano Kim*, Francois Ghiringhelli, Christelle de la Fouchardière, Ludovic Evesque, Denis Smith, Nicolas Badet, Emmanuelle Samalin, Daniel Lopez-Trabada Ataz, Aurelie Parzy, Jérôme Desramé, Nabil Baba Hamed, Bruno Buecher, David Tougeron, Olivier Bouché, Laetitia Dahan, Benoist Chibaudel, Farid El Hajbi, Laurent Mineur, Olivier Dubreuil, Meher Ben Abdelghani, Solange Pecout, Frederic Bibeau, Michael Herfs, Marie-Line Garcia, Aurelia Meurisse, Dewi Vernerey, Julien Taïeb, Christophe Borg
doi : 10.1016/S1470-2045(24)00081-0
Volume 25, Issue 4, April 2024, Pages 518-528
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
Iseult M Browne, Fabrice André, Sarat Chandarlapaty, Lisa A Carey, Nicholas C Turner
doi : 10.1016/S1470-2045(23)00676-9
Volume 25, Issue 4, April 2024, Pages e139-e151
The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions
Michael Schlander*, Wim van Harten†, Valesca P Retèl, Phu Duy Pham, Julie M Vancoppenolle, Jasper Ubels, Olaya Seoane L?pez, Camila Quirland, Felipe Maza, Eline Aas, Bernd Crusius, Agust?n Escobedo, Nora Franzen, Jeanette Fuentes-Cid, Diego Hernandez, Karla Hernandez-Villafuerte, Iva Kirac, Artus Paty, Thierry Philip, Sigbj?rn Smeland, Richard Sullivan, Elena Vanni, Sinisa Varga, Thomas Vermeulin, Rachel D Eckford
doi : 10.1016/S1470-2045(23)00636-8
Volume 25, Issue 4, April 2024, Pages e152-e163
Cancer control collaborations between China and African countries
Twalib Ngoma, Isaac Adewole, Victoria Ainsworth, David Chin, Jennifer Chin, Ahmed Elzawawy, Adedayo Joseph, Abba Mallum, Ntokozo Ndlovu, Mamsau Ngoma, Aishat Oladipo, William Swanson, Wilfred Ngwa
doi : 10.1016/S1470-2045(23)00634-4
Volume 25, Issue 4, April 2024, Pages e164-e172
Gastric signet-ring cell adenocarcinoma masquerading as sarcoidosis
Samy Belkaïd, Laura Crumbach, Axel de Bernardi, Sophie Darnis, Margot Bouquerel, Anne Neuhart, Souad Assaad, Mona Amini-Adle
doi : 16/S1470-2045(24)00105-0
Volume 25, Issue 4, April 2024, Page e173
